OB/GYN Annual Subject Index 2004

[ Subject | Author ]

Aging
Cardiovascular disease in postmenopausal women: emerging information about hormone therapy. Jun(suppl):38-44
Depression in the female geriatric patient. Jun(suppl):19-22
Driving safety and the elderly woman: considerations for the primary care physician. Jun(suppl):7-13
Infections in older women. Jun(suppl):30-37
Insomnia. Jun(suppl):14-18
Lifetime approach to osteoporosis. Jun(suppl):23-29
Minimizing loss. Jun(suppl):6

back to top

Alternative medicine
Nutritional influences on osteoporosis. Jul:35-42
Uterine fibroid management: considering all the options. Sep:19-23

back to top

Anesthesia
Obstetric anesthesia update. Dec:16-21

back to top

Bone densitometry
Estrogen and bone health. Feb(CME suppl):4-9
Osteoporosis: new treatments show tremendous promise. Nov(suppl):16-18

back to top

Cancer
Breast cancer early detection: you are part of the team! Nov(suppl):11-15
Cancer, sexuality, and sexual expression. Sep:35-36,41-42
Cervical cancer screening: revised guidelines. Dec:36-44
Clinical implications of BRCA1 and BRCA2 genes in hereditary breast and ovarian cancer. Mar:51-57
Clinical utility of ductal lavage in breast cancer detection. Oct:27-33
The evolving role of laparoscopic surgery for treatment of gynecologic masses and cancers. Apr:25-32
Leiomyosarcoma of the rectovaginal septum: case report and review of the literature. Dec:47-48,55
Progestogen in hormone therapy: recommendations for individualizing therapy. Apr:59-60
Unopposed estrogen and cancer. Feb(CME suppl):19-26
The women’s health initiative reports: critical review of the findings. Nov:23-29,54

back to top

Cardiovascular disorders
Cardiovascular disease in postmenopausal women: emerging information about hormone therapy. Jun(suppl):38-44
Low-risk patients undergoing cesarean delivery require prophylaxis against deep venous thrombosis. Jul:12-19
Overview of lipid therapy in women. Feb:39-53
Routine thromboprophylaxis in women undergoing cesarean delivery: wait for the evidence. Jul:13,23-27
Vasomotor and vascular considerations. Feb(CME suppl):10-12,17-18
The women's health initiative reports: critical review of the findings. Nov:23-29,54

back to top

Continuing medical education (CME)
Anatomical and neurodevelopmental effects of anticonvulsant drugs. Jul(CME suppl):4-5
Anticonvulsant drug use in women—implications for obstetric and gynecologic care. Jul(CME suppl):1
Diagnosis of polycystic ovary syndrome. Apr:33-41 [test 61-62]
Endometriosis, part 1: diagnosis and evaluation. Feb:32-38 [test 57-58]
Endometriosis, part 2: treatment options. Mar:26-33 [test 47-48]
Estrogen and bone health. Feb(CME suppl):4-9
Gynecologic and obstetric management of women on anticonvulsant drugs. Jul(CME suppl):5-6
Health concerns related to anticonvulsant drugs and reproductive and metabolic health. Jul(CME suppl):2-3
Hormonally associated migraine. Nov:16-22 [test 55-56]
Hysteroscopy: past, present, and virtual future. Jul:28-34 [test 55-56]
Influenza and other vaccinations important for women. Oct:34-40 [test 57-58]
Introduction [Where do we go from here…unopposed estrogen?] Feb(CME suppl):3
Irritable bowel syndrome: new perspectives on treatment. Jun:30-36 [test 53-54]
Managing anxiety disorders in women. Jan:36-43 [test 53-54]
Obstetric anesthesia update. Dec:16-21 [test 49-50]
Population-based preconception and prenatal cystic fibrosis carrier screening: clinical implementation challenges. Aug:10-14 [test 55-56]
Pregnancy, contraception, and epilepsy: what are the risks? May:31-35 [test 55-56]
Unopposed estrogen and cancer. Feb(CME suppl):19-26
Uterine fibroid management: considering all the options. Sep:19-23 [test 75-76]
Vasomotor and vascular considerations. Feb(CME suppl):10-12,17-18

back to top

Contraception and contraceptives
Beyond forty: do contraceptive needs change? Apr:42-43
The changing paradigm of reversible contraception. Apr(suppl):8-10
Contraception plus therapy. Sep(suppl):10-12
Contraceptive safety from a global perspective: the 2004 WHO medical eligibility criteria for contraception. Jun:50-52
Establishing a periodic well woman visit program. Apr(suppl):3-7
A healthy approach to contraception. Sep(suppl):8-9
Helping women make choices that facilitate successful contraceptive use. Apr(suppl):13-16
Insurance coverage and reproductive health options. Aug:44-46,59
Intrauterine contraception: time for a comeback. Sep:10-12,17-18
Introduction [Evolving paradigms in contraceptive care and the annual visit]. Apr(suppl):2
The IUD: time for a comeback. Nov(suppl):19-21
A new way to manage menstruation. Sep(suppl):5-7
Pregnancy, contraception, and epilepsy: what are the risks? May:31-35
Pregnancy testing: a "teachable moment". Dec:45-46,55
Researching your contraceptive options: the IUS. Sep(suppl):3-4

back to top

Dermatologic disorders
Infections in older women. Jun(suppl):30-37

back to top

Diagnostic tools
Bladder evaluation diary. Mar(suppl):15
Breast cancer early detection: you are part of the team! Nov(suppl):11-15
How to perform the potassium sensitivity test. Oct(suppl):7
Pelvic pain and urgency/frequency patient symptom scale. Mar(suppl):9 and Oct(suppl):8

back to top

Domestic abuse
Detecting domestic violence: to screen or not to screen? Apr:47-52,57

back to top

Editorials
Be ready. Apr:9,13
The beginning of the end of our specialty? Mar:6
Caring for the mature woman—here we go again. Sep:9
The challenge of managing chronic pain in primary care: what critical historical clues are we missing? Nov:8-9
An endangered species: the male trainee in obstetrics and gynecology. Jun:8,11
How do we read the medical literature? Jan:11-12
Liability tort reform: not a done deal. Aug:9,43
Minimizing loss. Jun(suppl):6
The physician as a risk manager. May:10
Physician's time: the neglected health care resource. Oct:8-9
This is my assistant, Dr Robot. Jul:8,11
WANTED: Effective patient education. Feb:9-10
You are a statistic (but probably don't know it!). Dec:11-12

back to top

Gastrointestinal disorders
Infections in older women. Jun(suppl):30-37
Irritable bowel syndrome: new perspectives on treatment. Jun:30-36

back to top

Genetics
Clinical implications of BRCA1 and BRCA2 genes in hereditary breast and ovarian cancer. Mar:51-57
Population-based preconception and prenatal cystic fibrosis carrier screening: clinical implementation challenges. Aug:10-14

back to top

Gynecologic disorders
Assessing abnormal uterine bleeding during menopause. Nov(suppl):22-23
Cervical cancer screening: revised guidelines. Dec:36-44
Clinical implications of BRCA1 and BRCA2 genes in hereditary breast and ovarian cancer. Mar:51-57
Clinical utility of ductal lavage in breast cancer detection. Oct:27-33
The diagnosis of congenital uterine anomalies: the role of 3-D ultrasonography. Mar:7-15
Diagnosis of polycystic ovary syndrome. Apr:33-41
Dyspareunia: a systematic approach to diagnosis. Mar:34-42
Endometrial evaluation: assessing perimenopausal and postmenopausal women. Nov:52-54
Endometriosis, part 1: diagnosis and evaluation. Feb:32-38
Endometriosis, part 2: treatment options. Mar:26-33
Enhancing ovulation induction: optimizing the clomiphene cycle with sequential estradiol and vaginal progesterone supplementation. Sep:49-56
The evolving role of laparoscopic surgery for treatment of gynecologic masses and cancers. Apr:25-32
Hysteroscopy: past, present, and virtual future. Jul:28-34
Images in women’s health. Jul:51-54; Sep:45-46
Laparoscopic pelvic reconstructive surgery. Oct:11-16,21-24
Management of benign adnexal masses: practical pearls for laparoscopic salpingo-oophorectomy. Jan:27-35
Nonsurgical and minimally invasive outpatient treatments for stress urinary incontinence and pelvic organ prolapse. May:45-54
Practical evaluation of the incontinent woman. Mar:16-25
Pubic symphysis diastasis during pregnancy. Sep:24-34
Sexual function in women with pelvic floor disorders. Nov:30,35-38
Uterine fibroid management: considering all the options. Sep:19-23
Uterine fibroids and sexual dysfunction: true, true, and related? Aug:24-26,31
Vaginal repair of pelvic organ prolapse: advantages and patient selection. Aug:32-43

back to top

Headache
The challenge of managing chronic pain in primary care: what critical historical clues are we missing? Nov:8-9
Hormonally associated migraine. Nov:16-22

back to top

Hormones and hormone therapy
Cardiovascular disease in postmenopausal women: emerging information about hormone therapy. Jun(suppl):38-44
Caring for the mature woman—here we go again. Sep:9
Effects of hormone supplementation on mood in women. Dec:13-15,30
Enhancing ovulation induction: optimizing the clomiphene cycle with sequential estradiol and vaginal progesterone supplementation. Sep:49-56
Estrogen and bone health. Feb(CME suppl):4-9
Introduction [Where do we go from here…unopposed estrogen?] Feb(CME suppl):3
NAMS publishes hormone therapy recommendations. Feb:54-56
Osteoporosis: new treatments show tremendous promise. Nov(suppl):16-18
Postmenopausal androgen therapy. Nov:41-44,49-51
Progestogen in hormone therapy: recommendations for individualizing therapy. Apr:59-60
Unopposed estrogen and cancer. Feb(CME suppl):19-26
Use of conjugated estrogens after the women’s health initiative. Jan(suppl):1-6
Vasomotor and vascular considerations. Feb(CME suppl):10-12,17-18
The women’s health initiative reports: critical review of the findings. Nov:23-29,54

back to top

Hysteroscopy
Hysteroscopy: past, present, and virtual future. Jul:28-34
Images in women’s health. Jul:51-54; Sep:45-46

back to top

Infections
Hepatitis C and pregnancy. Dec:22-24,29-30
Infections in older women. Jun(suppl):30-37

back to top

Laparoscopy
The evolving role of laparoscopic surgery for treatment of gynecologic masses and cancers. Apr:25-32
Laparoscopic pelvic reconstructive surgery. Oct:11-16,21-24
Management of benign adnexal masses: practical pearls for laparoscopic salpingo-oophorectomy. Jan:27-35
This is my assistant, Dr Robot. Jul:8,11

back to top

Menopause
Assessing abnormal uterine bleeding during menopause. Nov(suppl):22-23
Cardiovascular disease in postmenopausal women: emerging information about hormone therapy. Jun(suppl):38-44
Caring for the mature woman—here we go again. Sep:9
Effects of hormone supplementation on mood in women. Dec:13-15,30
Endometrial evaluation: assessing perimenopausal and postmenopausal women. Nov:52-54
Estrogen and bone health. Feb(CME suppl):4-9
Hormonally associated migraine. Nov:16-22
Introduction [Where do we go from here…unopposed estrogen?] Feb(CME suppl):3
Lifetime approach to osteoporosis. Jun(suppl):23-29
NAMS publishes hormone therapy recommendations. Feb:54-56
Nutritional influences on osteoporosis. Jul:35-42
Osteoporosis: new treatments show tremendous promise. Nov(suppl):16-18
Postmenopausal androgen therapy. Nov:41-44,49-51
Progestogen in hormone therapy: recommendations for individualizing therapy. Apr:59-60
Use of conjugated estrogens after the women’s health initiative. Jan(suppl):1-6
The women’s health initiative reports: critical review of the findings. Nov:23-29,54

back to top

Menstruation
Assessing abnormal uterine bleeding during menopause. Nov(suppl):22-23
Contraception plus therapy. Sep(suppl):10-12
Health concerns related to anticonvulsant drugs and reproductive and metabolic health. Jul(CME suppl):2-3
Hormonally associated migraine. Nov:16-22
Intrauterine contraception: time for a comeback. Sep:10-12,17-18
The IUD: time for a comeback. Nov(suppl):19-21
A new way to manage menstruation. Sep(suppl):5-7
Special concerns in caring for the female athlete. Aug:15-23

back to top

Musculoskeletal disorders
A targeted approach to musculoskeletal pain, part 1: mechanisms and diagnosis. May:36-43
A targeted approach to musculoskeletal pain, part 2: management and pharmacotherapy. Jun:37-39,43-48

back to top

Neurologic disorders
Anatomical and neurodevelopmental effects of anticonvulsant drugs. Jul(CME suppl):4-5
Anticonvulsant drug use in women—implications for obstetric and gynecologic care. Jul(CME suppl):1
Gynecologic and obstetric management of women on anticonvulsant drugs. Jul(CME suppl):5-6
Health concerns related to anticonvulsant drugs and reproductive and metabolic health. Jul(CME suppl):2-3
Pregnancy, contraception, and epilepsy: what are the risks? May:31-35

back to top

Nutrition
Living with interstitial cystitis. Mar(suppl):10-14
Nutritional influences on osteoporosis. Jul:35-42
Special concerns in caring for the female athlete. Aug:15-23

back to top

Obstetrics and gynecology
Caring for the mature woman—here we go again. Sep:9
An endangered species: the male trainee in obstetrics and gynecology. Jun:8,11
Establishing a periodic well woman visit program. Apr(suppl):3-7
Fetal death: detection and management. Dec:32-35
Helping women make choices that facilitate successful contraceptive use. Apr(suppl):13-16
Introduction [Evolving paradigms in contraceptive care and the annual visit]. Apr(suppl):2
Lights, camera, (legal) action: videotaping in the delivery room. Nov:10-15
Obstetric anesthesia update. Dec:16-21
Patient choice for elective cesarean delivery: report on a survey. May:12-21,54
Patient-requested cesarean delivery: is it time? Oct:41-44,49-51
Physician's time: the neglected health care resource. Oct:8-9
Pregnancy testing: a “teachable moment”. Dec:45-46,55
You are a statistic (but probably don't know it!). Dec:11-12

back to top

Osteoporosis
Estrogen and bone health. Feb(CME suppl):4-9
Lifetime approach to osteoporosis. Jun(suppl):23-29
Nutritional influences on osteoporosis. Jul:35-42
Osteoporosis: new treatments show tremendous promise. Nov(suppl):16-18
The women’s health initiative reports: critical review of the findings. Nov:23-29,54

back to top

Pain
The challenge of managing chronic pain in primary care: what critical historical clues are we missing? Nov:8-9
Dyspareunia: a systematic approach to diagnosis. Mar:34-42
Endometriosis, part 1: diagnosis and evaluation. Feb:32-38
Endometriosis, part 2: treatment options. Mar:26-33
Hormonally associated migraine. Nov:16-22
Interstitial cystitis. Apr:14-22,58
Interstitial cystitis: one woman's story. Mar(suppl):2-4
Living with interstitial cystitis. Mar(suppl):10-14
A targeted approach to musculoskeletal pain, part 1: mechanisms and diagnosis. May:36-43
A targeted approach to musculoskeletal pain, part 2: management and pharmacotherapy. Jun:37-39,43-48
Understanding chronic pelvic pain in women: diagnosing and managing women with interstitial cystitis. Oct(suppl):1-6
What is chronic pelvic pain of bladder origin? Mar(suppl):5-8

back to top

Patient education
Assessing abnormal uterine bleeding during menopause. Nov(suppl):22-23
Bladder evaluation diary. Mar(suppl):15
Breast cancer early detection: you are part of the team! Nov(suppl):11-15
Choosing the birth control method that's right for you. Apr(suppl):11-12
Contraception plus therapy. Sep(suppl):10-12
A healthy approach to contraception. Sep(suppl):8-9
Healthy travel tips. Nov(suppl):4-8
Interstitial cystitis: one woman's story. Mar(suppl):2-4
The IUD: time for a comeback. Nov(suppl):19-21
Living with interstitial cystitis. Mar(suppl):10-14
A new way to manage menstruation. Sep(suppl):5-7
Osteoporosis: new treatments show tremendous promise. Nov(suppl):16-18
Pelvic pain and urgency/frequency patient symptom scale. Mar(suppl):9 and Oct(suppl):8
The pros and cons of hormone therapy [handout]. Feb(CME suppl):13-16
Researching your contraceptive options: the IUS. Sep(suppl):3-4
Use of hormones during menopause. Jan(suppl):7
What is chronic pelvic pain of bladder origin? Mar(suppl):5-8

What you should know about...

Adult immunizations. Oct:59-60
Endometriosis. Mar:49-50
Hemorrhoids. Jan:51-52
Intrauterine contraception. Sep:69-70
Irritable bowel syndrome. Jun:55-56
Keeping your heart healthy. Feb:59-60
Migraine. Nov:57-58
Nutrition and osteoporosis. Jul:57-58
Pain relief. Aug:57-58
Pap smears. Dec:51-52
Polycystic ovary syndrome. Apr:65-66
Social anxiety disorder. May:57-58

back to top

Pharmacotherapy
Anatomical and neurodevelopmental effects of anticonvulsant drugs. Jul(CME suppl):4-5
Anticonvulsant drug use in women—implications for obstetric and gynecologic care. Jul(CME suppl):1
Gynecologic and obstetric management of women on anticonvulsant drugs. Jul(CME suppl):5-6
Health concerns related to anticonvulsant drugs and reproductive and metabolic health. Jul(CME suppl):2-3
Hormonally associated migraine. Nov:16-22
Hypoactive sexual desire disorder in the reproductive-aged woman. Sep:58-68
Insomnia. Jun(suppl):14-18
Interstitial cystitis: one woman's story. Mar(suppl):2-4
Irritable bowel syndrome: new perspectives on treatment. Jun:30-36
Living with interstitial cystitis. Mar(suppl):10-14
Managing anxiety disorders in women. Jan:36-43
Osteoporosis: new treatments show tremendous promise. Nov(suppl):16-18
Overview of lipid therapy in women. Feb:39-53
Selective serotonin reuptake inhibitors and sexual dysfunction in women. Jun:16-24,29
A targeted approach to musculoskeletal pain, part 1: mechanisms and diagnosis. May:36-43
A targeted approach to musculoskeletal pain, part 2: management and pharmacotherapy. Jun:37-39,43-48
Understanding chronic pelvic pain in women: diagnosing and managing women with interstitial cystitis. Oct(suppl):1-6
Uterine fibroid management: considering all the options. Sep:19-23

back to top

Pregnancy
Anatomical and neurodevelopmental effects of anticonvulsant drugs. Jul(CME suppl):4-5
Anticonvulsant drug use in women—implications for obstetric and gynecologic care. Jul(CME suppl):1
Beyond forty: do contraceptive needs change? Apr:42-43
Enhancing ovulation induction: optimizing the clomiphene cycle with sequential estradiol and vaginal progesterone supplementation. Sep:49-56
Fetal death: detection and management. Dec:32-35
Group B Streptococcus: a culture-based prevention strategy. Feb:24-30
Gynecologic and obstetric management of women on anticonvulsant drugs. Jul(CME suppl):5-6
Health concerns related to anticonvulsant drugs and reproductive and metabolic health. Jul(CME suppl):2-3
Hepatitis C and pregnancy. Dec:22-24,29-30
Hormonally associated migraine. Nov:16-22
Images in women’s health. Sep:45-46
Influenza and other vaccinations important for women. Oct:34-40
Innovations for an age-old problem: hemorrhoids in the female patient. Jan:17-26
Low-risk patients undergoing cesarean delivery require prophylaxis against deep venous thrombosis. Jul:12-19
Patient choice for elective cesarean delivery: report on a survey. May:12-21,54
Patient-requested cesarean delivery: is it time? Oct:41-44,49-51
Population-based preconception and prenatal cystic fibrosis carrier screening: clinical implementation challenges. Aug:10-14
Preconception screening and counseling. Oct:52-55
Pregnancy, contraception, and epilepsy: what are the risks? May:31-35
Pregnancy outcome in motor vehicle accidents. Feb:11-23
Pregnancy testing: a “teachable moment”. Dec:45-46,55
Pubic symphysis diastasis during pregnancy. Sep:24-34
Routine thromboprophylaxis in women undergoing cesarean delivery: wait for the evidence. Jul:13,23-27
Urethral diverticulum in a pregnant patient. Mar:45-46

back to top

Prenatal screening
Gynecologic and obstetric management of women on anticonvulsant drugs. Jul(CME suppl):5-6
Population-based preconception and prenatal cystic fibrosis carrier screening: clinical implementation challenges. Aug:10-14

back to top

Preventive medicine
Clinical utility of ductal lavage in breast cancer detection. Oct:27-33
Group B Streptococcus: a culture-based prevention strategy. Feb:24-30
Influenza and other vaccinations important for women. Oct:34-40
Low-risk patients undergoing cesarean delivery require prophylaxis against deep venous thrombosis. Jul:12-19
Routine thromboprophylaxis in women undergoing cesarean delivery: wait for the evidence. Jul:13,23-27

back to top

Psychiatric disorders
Depression in the female geriatric patient. Jun(suppl):19-22
Effects of hormone supplementation on mood in women. Dec:13-15,30
Managing anxiety disorders in women. Jan:36-43
Selective serotonin reuptake inhibitors and sexual dysfunction in women. Jun:16-24,29
Social anxiety disorder. May 25-30

back to top

Psychological issues
Cancer, sexuality, and sexual expression. Sep:35-36,41-42
The challenge of managing chronic pain in primary care: what critical historical clues are we missing? Nov:8-9
Fetal death: detection and management. Dec:32-35
Hypoactive sexual desire disorder in the reproductive-aged woman. Sep:58-68
Living with interstitial cystitis. Mar(suppl):10-14

back to top

Pulmonary disorders
Population-based preconception and prenatal cystic fibrosis carrier screening: clinical implementation challenges. Aug:10-14

back to top

Radiography
Images in women’s health. Jul:51-54; Sep:45-46

back to top

Regulatory issues
Insurance coverage and reproductive health options. Aug:44-46,59
Liability tort reform: not a done deal. Aug:9,43

back to top

Respiratory disorders
Infections in older women. Jun(suppl):30-37

back to top

Screening
Breast cancer early detection: you are part of the team! Nov(suppl):11-15
Cervical cancer screening: revised guidelines. Dec:36-44
Clinical implications of BRCA1 and BRCA2 genes in hereditary breast and ovarian cancer. Mar:51-57
Clinical utility of ductal lavage in breast cancer detection. Oct:27-33
Detecting domestic violence: to screen or not to screen? Apr:47-52,57
Endometrial evaluation: assessing perimenopausal and postmenopausal women. Nov:52-54
Establishing a periodic well woman visit program. Apr(suppl):3-7
Group B Streptococcus: a culture-based prevention strategy. Feb:24-30
Overview of lipid therapy in women. Feb:39-53
Population-based preconception and prenatal cystic fibrosis carrier screening: clinical implementation challenges. Aug:10-14
Preconception screening and counseling. Oct:52-55

back to top

Sexual assault
Expert witness testimony in sexual assault. Jun:12-15

back to top

Sexual health
Cancer, sexuality, and sexual expression. Sep:35-36,41-42
Dyspareunia: a systematic approach to diagnosis. Mar:34-42
Female sexual dysfunction in primary care: when is referral to a sex therapist indicated? Jul:47-50
Hypoactive sexual desire disorder in the reproductive-aged woman. Sep:58-68
Postmenopausal androgen therapy. Nov:41-44,49-51
Selective serotonin reuptake inhibitors and sexual dysfunction in women. Jun:16-24,29
Sex with oneself. Jan:44-46
Sexual function in women with pelvic floor disorders. Nov:30,35-38
Uterine fibroids and sexual dysfunction: true, true, and related? Aug:24-26,31

back to top

Surgery
The evolving role of laparoscopic surgery for treatment of gynecologic masses and cancers. Apr:25-32
Hysteroscopy: past, present, and virtual future. Jul:28-34
Images in women’s health. Jul:51-54
Innovations for an age-old problem: hemorrhoids in the female patient. Jan:17-26
Laparoscopic pelvic reconstructive surgery. Oct:11-16,21-24
Leiomyosarcoma of the rectovaginal septum: case report and review of the literature. Dec:47-48,55
Low-risk patients undergoing cesarean delivery require prophylaxis against deep venous thrombosis. Jul:12-19
Management of benign adnexal masses: practical pearls for laparoscopic salpingo-oophorectomy. Jan:27-35
Nonsurgical and minimally invasive outpatient treatments for stress urinary incontinence and pelvic organ prolapse. May:45-54
Patient choice for elective cesarean delivery: report on a survey. May:12-21,54
Patient-requested cesarean delivery: is it time? Oct:41-44,49-51
Routine thromboprophylaxis in women undergoing cesarean delivery: wait for the evidence. Jul:13,23-27
This is my assistant, Dr Robot. Jul:8,11
Understanding chronic pelvic pain in women: diagnosing and managing women with interstitial cystitis. Oct(suppl):1-6
Urethral diverticulum in a pregnant patient. Mar:45-46
Uterine fibroid management: considering all the options. Sep:19-23
Vaginal repair of pelvic organ prolapse: advantages and patient selection. Aug:32-43
You are a statistic (but probably don't know it!). Dec:11-12

back to top

Ultrasonography
The diagnosis of congenital uterine anomalies: the role of 3-D ultrasonography. Mar:7-15
Images in women’s health. Jul:51-54

back to top

Urologic disorders
Infections in older women. Jun(suppl):30-37
Interstitial cystitis. Apr:14-22,58
Interstitial cystitis: one woman's story. Mar(suppl):2-4
Laparoscopic pelvic reconstructive surgery. Oct:11-16,21-24
Living with interstitial cystitis. Mar(suppl):10-14
Nonsurgical and minimally invasive outpatient treatments for stress urinary incontinence and pelvic organ prolapse. May:45-54
Practical evaluation of the incontinent woman. Mar:16-25
Understanding chronic pelvic pain in women: diagnosing and managing women with interstitial cystitis. Oct(suppl):1-6
Vaginal repair of pelvic organ prolapse: advantages and patient selection. Aug:32-43
What is chronic pelvic pain of bladder origin? Mar(suppl):5-8

back to top

Urogynecology
Laparoscopic pelvic reconstructive surgery. Oct:11-16,21-24
Nonsurgical and minimally invasive outpatient treatments for stress urinary incontinence and pelvic organ prolapse. May:45-54
Practical evaluation of the incontinent woman. Mar:16-25
Sexual function in women with pelvic floor disorders. Nov:30,35-38
Understanding chronic pelvic pain in women: diagnosing and managing women with interstitial cystitis. Oct(suppl):1-6
Vaginal repair of pelvic organ prolapse: advantages and patient selection. Aug:32-43

back to top